Onxeo to attend Key Investor and Partnering Conferences in the Coming Months
Onxeo to attend Key Investor and Partnering Conferences in the Coming Months
Paris (France), September 13, 2018 – 05:45 pm CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO - FR0010095596), a clinical-stage biotechnology company specializing in the development of innovative drugs in oncology, today announced that its management team will attend the following key investor and partnering conferences in the coming months:
European Large & Midcap Event
October 8-9, 2018
Paris, France
BIO-Europe
November 5-7, 2018
Copenhagen, Denmark
Boursocap / Les Echos – Investir Event
November 21, 2018
Paris, France
Investor meetings during the JP Morgan Healthcare Conference 2019
January 7-10, 2019
San Francisco, US
BioMed Event
January 22, 2019
Paris, France